Page 74 - 《中国药房》2023年21期
P. 74
Hepatitis C Group HIV/AIDS,Chinese Association of In‐ 167-168.
fectious Diseases,Chinese Center for Disease Control and [12] 姚仕堂,何春燕,曹东冬,等. 云南省德宏傣族景颇族自
Prevention. Guidelines for AIDS diagnosis and treatment 治州 2004-2018 年启动抗病毒治疗后 HIV/AIDS 贫血
in China:2021 edition[J]. Chin J AIDS STD,2021,27 发病及危险因素回顾性队列研究[J]. 中华流行病学杂
(11):1182-1201. 志,2021,42(7):1218-1224.
[ 4 ] 罗纪燕 . 艾滋病传播的途径及预防措施[J]. 健康必读, YAO S T,HE C Y,CAO D D,et al. A retrospective cohort
2021(4):3. study of incidence of anemia and risk factors in HIV/
LUO J Y. Ways of AIDS transmission and preventive mea‐ AIDS patients with access to antiretroviral therapy in De‐
sures[J]. Health Readm,2021(4):3. hong Jingpo and Dai Autonomous Prefecture in Yunnan
[ 5 ] 王丽,解洪明,金春英,等. 含齐多夫定或替诺福韦的两 province,2004-2018[J]. Chin J Epidemiol,2021,42(7):
组治疗方案的早期疗效评价[J]. 国际免疫学杂志,2018, 1218-1224.
41(2):154-157. [13] LEVINE A M,BERHANE K,MASRI-LAVINE L,et al.
WANG L,XIE H M,JIN C Y,et al. Evaluation of early ef‐ Prevalence and correlates of anemia in a large cohort of
ficacy of treatment regimens containing zidovudine or te‐ HIV-infected women:women’s interagency HIV study[J].
nofovir[J]. Int J Immunol,2018,41(2):154-157. J Acquir Immune Defic Syndr,2001,26(1):28-35.
[ 6 ] GETANEH Z,WALE W,CHANIE B,et al. Magnitude [14] VOLBERDING P A,LEVINE A M,DIETERICH D,et al.
and associated factors of anemia among AZT based Anemia in HIV infection:clinical impact and evidence-
HAART experienced adult HIV patients at University of based management strategies[J]. Clin Infect Dis,2004,38
Gondar Comprehensive Specialized Referral Hospital, (10):1454-1463.
Northwest,Ethiopia,2019:a retrospective cohort study[J]. [15] 杜红,赵柳红,覃忠于,等. HIV/AIDS患者高效抗逆转录
BMC Infect Dis,2021,21(1):1016. 病毒治疗过程中发生骨髓抑制的影响因素[J]. 实用医学
[ 7 ] LIU K,SUN Y,LIU D J,et al. Mitochondrial toxicity 杂志,2015,31(17):2844-2848.
studied with the PBMC of children from the Chinese na‐ DU H,ZHAO L H,QIN Z Y,et al. Influencing factors of
tional pediatric highly active antiretroviral therapy cohort bone marrow suppression in HIV/AIDS patients during
[J]. PLoS One,2013,8(2):e57223. highly active antiretroviral therapy[J]. J Pract Med,2015,
[ 8 ] PHE T,THAI S,VENG C,et al. Risk factors of treatment- 31(17):2844-2848.
limiting anemia after substitution of zidovudine for stavu‐ [16] 杜红,赵柳红,覃忠于,等 . HIV 感染/AIDS 住院患者高
dine in HIV-infected adult patients on antiretroviral treat‐ 效抗逆转录病毒治疗中发生骨髓抑制致死亡的影响因
ment[J]. PLoS One,2013,8(3):e60206. 素[J]. 中国药房,2015,26(35):4951-4954.
[ 9 ] AGARWAL D,CHAKRAVARTY J,CHAUBE L,et al. DU H,ZHAO L H,QIN Z Y,et al. Effects of myelosup‐
High incidence of zidovudine induced anaemia in HIV in‐ pression in HIV/AIDS patients on death during HARRT
fected patients in eastern India[J]. Indian J Med Res, treatment[J]. China Pharm,2015,26(35):4951-4954.
2010,132:386-389. [17] 吴泓靓,陈碧正. 基于Logistic回归分析艾滋病高效抗逆
[10] FEREDE G,WONDIMENEH Y. Prevalence and related 转录病毒治疗患者病毒载量抑制失败的高危因素[J]. 中
factors of anemia in HAART-naive HIV positive patients 国性科学,2021,30(12):150-152.
at Gondar University Hospital,Northwest Ethiopia[J]. WU H J,CHEN B Z. High-risk factors for viral load inhi‐
BMC Hematol,2013,13(1):8. bition failure in AIDS patients with HAART:a Logistic re‐
[11] 陆远炎. 30例齐多夫定片所致贫血的临床分析[J]. 中国 gression analysis[J]. Chin J Hum Sex,2021,30(12):
医药指南,2013,11(18):167-168. 150-152.
LU Y Y. Clinical analysis of 30 cases of anemia caused by (收稿日期:2023-03-28 修回日期:2023-10-11)
zidovudine tablets[J]. Guide China Med,2013,11(18): (编辑:胡晓霖)
· 2624 · China Pharmacy 2023 Vol. 34 No. 21 中国药房 2023年第34卷第21期